Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure

Nephrology Dialysis Transplantation

Volumn 17, Issue 8, 2002, Pages 1518-1521

  Chan, Christopher ^a   Floras, John S ^b   Miller, Judith A ^a   Pierratos, Andreas ^c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d NONE   (Canada)

Author keywords

Congestive heart failure; Daily haemodialysis; Ejection fraction; End stage renal disease; Extracellular fluid; Home haemodialysis; Nocturnal haemodialysis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; RADIOISOTOPE; UREMIC TOXIN; VASOACTIVE AGENT; VASODILATOR AGENT;

ADULT; ARTERIAL PRESSURE; ARTICLE; BIOENERGY; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; DRUG USE; EXTRACELLULAR FLUID; HEART DISEASE; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE CONTRACTILITY; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMPEDANCE; KIDNEY FAILURE; MORTALITY; NIGHT; PRIORITY JOURNAL; RISK FACTOR; SCINTIANGIOGRAPHY; SUBSTITUTION THERAPY; SYSTOLIC BLOOD PRESSURE; VASOCONSTRICTION; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; HEART STROKE VOLUME; HEMODYNAMICS; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PULSE RATE; RENAL REPLACEMENT THERAPY; TIME;

BLOOD PRESSURE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY FAILURE, CHRONIC; PULSE; RENAL DIALYSIS; RISK FACTORS; STROKE VOLUME; TIME FACTORS;

EID: 0035993293     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.8.1518     Document Type: Article

References (20)

1. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors
2. Uremic cardiomyopathy-effect of hemodialysis on left ventricular function in end-stage renal failure
3. Effect of hemodialysis on left ventricular function: Dissociation of changes in filling volume and in contractile state
4. Diastolic ventricular interaction in chronic heart failure
5. Nocturnal hemodialysis: Three-year experience
6. Regression of left ventricular hypertrophy after conversion to nocturnal hemodalysis
7. Hypertension in hemodialysis patients: Is it only hypervolemia?
8. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis
9. Clinical assessment of dry weight
10. Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method
11. Dilated cardiomyopathy in dialysis patients-beneficial effects of carvediol: A double-blind, placebo-controlled trial
12. Maximizing management of patients with decompensated heart failure
13. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration
14. The role of angiotensin II, endothelin-1 and transforming growth factor-beta as autocrine/paracrine mediators of stretch-induced cardiomyocyte hypertrophy
15. Early sequence of cardiac adaptations and growth factor formation in pressure-and volume-overload hypertrophy
16. In vitro approach to 'uremic cardiomyopathy'
17. Impact of renal transplantation on uremic cardiomyopathy
18. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy
19. Malnutrition, cardiac disease and mortality: An integrated point of view